Cancers We Treat

Home / Sovereign Health Cancer Care / Cancers We Treat

The physicians of Sovereign Health Cancer Care are fellowship-trained to treat malignancies of any site with the evidence-based techniques and treatments best suited to each patient’s specific needs. Our experts have published extensively in the nations’ leading peer-reviewed journals and have vast experience treating cancers of all types, including prostate, breast, lung, bladder, head and neck, and brain cancer, as well as cancers of the gastrointestinal and gynecologic systems. This section contains introductory information on some of the cancers we treat most often.

Prostate Cancer

Prostate cancer is the most common cancer in American men other than skin cancer. One in every seven men will develop prostate cancer in his lifetime.

Breast Cancer

The American Cancer Society estimates that about 231,840 new cases of invasive breast cancer will be diagnosed in women in the United States this year.

Lung Cancer

Lung cancer is the number one cause of death from cancer in men and women in the United States. The American Cancer Society estimates that there will be 158,040 deaths from lung cancer this year.

Bladder Cancer

The American Cancer Society estimates that about 74,000 new cases of bladder cancer will be diagnosed in the United States in 2015.

Colon, Rectal, and Anal Cancers

The American Cancer Society estimates that in 2015, there will be 93,090 new cases of colon cancer in the United States, 39,610 new cases of rectal cancer, and 7,270 new cases of anal cancer.

Gynecologic Cancers

Gynecologic cancers are malignancies of the female reproductive system, and include cervical, uterine (endometrial), ovarian, vaginal, and vulvar cancers.

Head and Neck Cancers

The American Cancer Society estimates that more than 53,000 people in the United States will be diagnosed with head and neck cancer in 2015.

Brain Cancer

The American Cancer Society estimates that 22,850 adults and 4,000 children in the United States will be diagnosed with malignant tumors of the brain and spinal cord in 2015.